Autophagy Modulation in Disease Therapy: Where Do We Stand?

Current Pathobiology Reports

Volumn 1, Issue 4, 2013, Pages 239-245

  Nelson, Michael P ^a   Shacka, John J ^a,b  

^a University of Alabama at Birmingham   (United States)

^b BIRMINGHAM VA MEDICAL CENTER   (United States)

Author keywords

Alzheimer s disease; Autophagy; Cancer; Disease treatment; Ischemia reperfusion; Neurodegeneration; Neuropathology; Parkinson s disease; Pharmacological therapy; Stroke

Indexed keywords

EID: 84992225972     PISSN: None     EISSN: 2167485X     Source Type: Journal    
DOI: 10.1007/s40139-013-0032-9     Document Type: Review

References (67)

1. Oczypok E, Oury T, Chu C (2013) It’s a cell-eat-cell world: autophagy and phagocytosis. Am J Pathol 182(3):612–622
2. Symposium on Lysosomes, D.D.C.D.R.A.V.S.C.M.P.C.F. Ciba Foundation Symposium: Lysosomes [proceedings]. 1963; Available from: http://catalog.hathitrust.org/api/volumes/oclc/1749447.html
3. Klionsky D, Codogno P (2013) The mechanism and physiological function of macroautophagy. J Innate Immun 5(5):427–433
4. Li W-w, Li J, Bao J-k (2012) Microautophagy: lesser-known self-eating. Cell Mol Life Sci 69(7):1125–1136
5. Arias E, Cuervo A (2011) Chaperone-mediated autophagy in protein quality control. Curr Opin Cell Biol 23(2):184–189
6. Thomas R, Gustafsson A (2013) Mitochondrial autophagy. Circ J 77(10):2449–2454
7. Christian P, Sacco J, Adeli K (2013) Autophagy: emerging roles in lipid homeostasis and metabolic control. Biochim Biophys Acta 1831(4):819–824
8. Jo E-K et al (2013) Roles of autophagy in elimination of intracellular bacterial pathogens. Frontiers Immunol 4:97
9. Klionsky DJ et al (2008) Guidelines for the use and interpretation of assays for monitoring autophagy in higher eukaryotes. Autophagy 4(2):151–175
10. •• Klionsky D et al (2012) Guidelines for the use and interpretation of assays for monitoring autophagy. Autophagy 8(4):445–544. This publication is especially significant, as it provides useful guidelines developed collaboratively for anyone considering, conducting, or reviewing autophagy research. The author would go as far as suggesting that it be required reading.
11. Hara T et al (2006) Suppression of basal autophagy in neural cells causes neurodegenerative disease in mice. Nature 441(7095):885–889
12. Gozuacik D, Kimchi A (2007) Autophagy and cell death. Curr Top Dev Biol 78:217–245
13. Levy JM, Thorburn A (2011) Targeting autophagy during cancer therapy to improve clinical outcomes. Pharmacol Ther 131(1):130–141
14. Liu H., Z. He, H.-U. Simon (2013) Targeting autophagy as a potential therapeutic approach for melanoma therapy. Seminars in cancer biology
15. Lu S-Z, Harrison-Findik D (2013) Autophagy and cancer. World J Biol Chem 4(3):64–70
16. Motzer R et al (2013) Pazopanib versus sunitinib in metastatic renal-cell carcinoma. N Engl J Med 369(8):722–731
17. Sternberg C et al (2010) Pazopanib in locally advanced or metastatic renal cell carcinoma: results of a randomized phase III trial. J Clin Oncol 28(6):1061–1068
18. van der Graaf W et al (2012) Pazopanib for metastatic soft-tissue sarcoma (PALETTE): a randomised, double-blind, placebo-controlled phase 3 trial. Lancet 379(9829):1879–1886
19. McCann L et al (2010) An indirect comparison analysis of pazopanib versus other agents in metastatic renal cell carcinoma (mRCC). J Clin Oncol 28(15 Suppl):e15128
20. Santoni M et al (2013) Pazopanib and sunitinib trigger autophagic and non-autophagic death of bladder tumour cells. Br J Cancer. doi:10.1038/bjc.2013.420
21. Ha S-D et al (2010) Cathepsin B-mediated autophagy flux facilitates the anthrax toxin receptor 2-mediated delivery of anthrax lethal factor into the cytoplasm. J Biol Chem 285(3):2120–2129
22. Minarini A et al (2013) Synthetic polyamines activating autophagy: effects on cancer cell death. Eur J Med Chem 67C:359–366
23. Kessel D, Vicente M, Reiners J (2006) Initiation of apoptosis and autophagy by photodynamic therapy. Lasers Surg Med 38(5):482–488
24. Milla Sanabria L et al (2013) Direct and indirect photodynamic therapy effects on the cellular and molecular components of the tumor microenvironment. Biochim Biophys Acta 1835(1):36–45
25. Sparsa A et al (2013) Photodynamic treatment induces cell death by apoptosis or autophagy depending on the melanin content in two B16 melanoma cell lines. Oncol Rep 29(3):1196–1200
26. Monma H et al (2013) The HSP70 and autophagy inhibitor pifithrin-μ enhances the antitumor effects of TRAIL on human pancreatic cancer. Mol Cancer Ther 12(4):341–351
27. Fourie A et al (1997) HSP70 binding sites in the tumor suppressor protein p53. J Biol Chem 272(31):19471–19479
28. Leu J et al (2009) A small molecule inhibitor of inducible heat shock protein 70. Mol Cell 36(1):15–27
29. Leu J et al (2011) HSP70 inhibition by the small-molecule 2-phenylethynesulfonamide impairs protein clearance pathways in tumor cells. Mol Cancer Res 9(7):936–947
30. Ranjan K et al (2013) Regulation of HA14-1 mediated oxidative stress, toxic response, and autophagy by curcumin to enhance apoptotic activity in human embryonic kidney cells. BioFactors (Oxford, England). doi:10.1002/biof.1098
31. Aoki H et al (2007) Evidence that curcumin suppresses the growth of malignant gliomas in vitro and in vivo through induction of autophagy: role of Akt and extracellular signal-regulated kinase signaling pathways. Mol Pharmacol 72(1):29–39
32. Demetri G et al (2006) Efficacy and safety of sunitinib in patients with advanced gastrointestinal stromal tumour after failure of imatinib: a randomised controlled trial. Lancet 368(9544):1329–1338
33. Motzer R et al (2007) Sunitinib versus interferon alfa in metastatic renal-cell carcinoma. N Engl J Med 356(2):115–124
34. Gotink K et al (2011) Lysosomal sequestration of sunitinib: a novel mechanism of drug resistance. Clin Cancer Res 17(23):7337–7346
35. Funk R, Krise J (2012) Cationic amphiphilic drugs cause a marked expansion of apparent lysosomal volume: implications for an intracellular distribution-based drug interaction. Mol Pharm 9(5):1384–1395
36. Nadanaciva S et al (2011) A high content screening assay for identifying lysosomotropic compounds. Toxicol Vitro 25(3):715–723
37. Kitagawa K (2012) Ischemic tolerance in the brain: endogenous adaptive machinery against ischemic stress. J Neurosci Res 90(5):1043–1054
38. Papadakis M et al (2013) Tsc1 (hamartin) confers neuroprotection against ischemia by inducing autophagy. Nat Med 19(3):351–357
39. Liu M et al (2010) Resveratrol inhibits mTOR signaling by promoting the interaction between mTOR and DEPTOR. J Biol Chem 285(47):36387–36394
40. Li L et al (2013) Resveratrol modulates autophagy and NF-κB activity in a murine model for treating non-alcoholic fatty liver disease. Food Chem Toxicol. doi:10.1016/j.fct.2013.08.036
41. Huang J, Upadhyay U, Tamargo R (2006) Inflammation in stroke and focal cerebral ischemia. Surg Neurol 66(3):232–245
42. Jiang Y et al (2012) Tetracycline inhibits local inflammation induced by cerebral ischemia via modulating autophagy. PloS One. doi:10.1371/journal.pone.0048672
43. Jin R, Yang G, Li G (2010) Inflammatory mechanisms in ischemic stroke: role of inflammatory cells. J Leukoc Biol 87(5):779–789
44. Lin TN (2005) 15d-Prostaglandin J2 Protects Brain From Ischemia-Reperfusion Injury. Arterioscler Thromb Vasc Biol 26(3):481–487
45. Wu J-S et al (2009) Ligand-activated peroxisome proliferator-activated receptor-gamma protects against ischemic cerebral infarction and neuronal apoptosis by 14-3-3 epsilon upregulation. Circulation 119(8):1124–1134
46. Martínez-Gras I et al (2011) The anti-inflammatory prostaglandin 15d-PGJ2 and its nuclear receptor PPARgamma are decreased in schizophrenia. Schizophr Res 128(1–3):15–22
47. Xu F et al (2013) Peroxisome proliferator-activated receptor-γ agonist 15d-prostaglandin J2 mediates neuronal autophagy after cerebral ischemia-reperfusion injury. PloS One. doi:10.1371/journal.pone.0055080
48. Harris H, Rubinsztein D (2012) Control of autophagy as a therapy for neurodegenerative disease. Nat Rev Neurol 8(2):108–117
49. Sarkar S et al (2007) Trehalose, a novel mTOR-independent autophagy enhancer, accelerates the clearance of mutant huntingtin and alpha-synuclein. J Biol Chem 282(8):5641–5652
50. Chen Q, Haddad G (2004) Role of trehalose phosphate synthase and trehalose during hypoxia: from flies to mammals. J Exp Biol 207(Pt 18):3125–3129
51. Aguib Y et al (2009) Autophagy induction by trehalose counteracts cellular prion infection. Autophagy 5(3):361–369
52. Krüger U et al (2012) Autophagic degradation of tau in primary neurons and its enhancement by trehalose. Neurobiol Aging 33(10):2291–2305
53. Schaeffer V, Goedert M (2012) Stimulation of autophagy is neuroprotective in a mouse model of human tauopathy. Autophagy 8(11):1686–1687
54. Ehrnhoefer D, Wong B, Hayden M (2011) Convergent pathogenic pathways in Alzheimer’s and Huntington’s diseases: shared targets for drug development. Nat Rev Drug Discovery 10(11):853–867
55. Wong M (2013) Mammalian target of rapamycin (mTOR) pathways in neurological diseases. Biomed J 36(2):40–50
56. Pan T et al (2008) Neuroprotection of rapamycin in lactacystin-induced neurodegeneration via autophagy enhancement. Neurobiol Dis 32(1):16–25
57. Sarkar S et al (2005) Lithium induces autophagy by inhibiting inositol monophosphatase. J Cell Biol 170(7):1101–1111
58. Parr C et al (2012) Glycogen synthase kinase 3 inhibition promotes lysosomal biogenesis and autophagic degradation of the amyloid-β precursor protein. Mol Cell Biol 32(21):4410–4418
59. Ashe K, Aguzzi A (2013) Prions, prionoids and pathogenic proteins in Alzheimer disease. Prion 7(1):55–59
60. • Karapetyan Y et al (2013) Unique drug screening approach for prion diseases identifies tacrolimus and astemizole as antiprion agents. Proc Natl Acad Sci USA 110(17):7044–7049. This publication, while very specific to prions, provides strong evidence that autophagy inhibition could be beneficial in treatment of neurodegenerative diseases with protein aggregate characteristics.
61. Chong C et al (2006) A clinical drug library screen identifies astemizole as an antimalarial agent. Nat Chem Biol 2(8):415–416
62. Heiseke A et al (2009) Lithium induces clearance of protease resistant prion protein in prion-infected cells by induction of autophagy. J Neurochem 109(1):25–34
63. Shacka J et al (2006) Bafilomycin A1 inhibits chloroquine-induced death of cerebellar granule neurons. Mol Pharmacol 69(4):1125–1136
64. Waterkeyn C et al (1987) Uptake, subcellular distribution and biotransformation of 3H-labelled astemizole in cultured rat hepatocytes. Biochem Pharmacol 36(23):4129–4136
65. Angot E, Brundin P (2009) Dissecting the potential molecular mechanisms underlying alpha-synuclein cell-to-cell transfer in Parkinson’s disease. Parkinsonism Relat Disord 15(Suppl 3):7
66. Jucker M, Walker L (2011) Pathogenic protein seeding in Alzheimer disease and other neurodegenerative disorders. Ann Neurol 70(4):532–540
67. Malchiodi-Albedi F et al (2011) Amyloid oligomer neurotoxicity, calcium dysregulation, and lipid rafts. Int J Alzheimer’s Dis 2011:906964